Pular para o conteúdo
Ataxia cerebelosa autossômica dominante tipo I
ORPHA:94145DOENÇA RARA
Esta doença tem causa genética. Recomendamos procurar um médico geneticista para diagnóstico, exames genéticos e aconselhamento familiar.
neuroInício todas idadesHerança AD
Também conhecida comoADCA1ADCAIADCASCAs
Sinônimos clínicos: ADCA1

A Ataxia Cerebelar Autossômica Dominante (ADCA) tipo I é um grupo de ataxias espinocerebelares (SCAs) que se caracteriza pela falta de coordenação (ataxia), além de outros problemas neurológicos. Entre eles, estão dificuldades nos movimentos dos olhos, problemas de memória e raciocínio, descontrole e rigidez muscular, e pode afetar também a fala, a deglutição, a respiração, a medula espinhal e os nervos periféricos (dos braços e pernas).

Em construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

A Ataxia Cerebelar Autossômica Dominante tipo I reúne um grupo de condições genéticas raras que provocam perda progressiva da coordenação motora e do equilíbrio. No dia a dia, a família costuma notar passos mais abertos ao caminhar, tremores nos braços, rigidez e movimentos oculares anormais. A condição não consta na lista oficial de PCDTs de doenças raras do Ministério da Saúde e não tem tratamento farmacológico específico fornecido pelo SUS. O acompanhamento médico apoia-se em exames genéticos e programas de reabilitação física e motora na rede de saúde para promover qualidade de vida.

📋
Informacoes curadas por IA — podem conter imprecisoes

A Ataxia Cerebelar Autossômica Dominante (ADCA) tipo I é um grupo de ataxias espinocerebelares (SCAs) que se caracteriza pela falta de coordenação (ataxia), além de outros problemas neurológicos. Entre eles, estão dificuldades nos movimentos dos olhos, problemas de memória e raciocínio, descontrole e rigidez muscular, e pode afetar também a fala, a deglutição, a respiração, a medula espinhal e os nervos periféricos (dos braços e pernas).

Publicações científicas
23 artigos
Último publicado: 2014 Jan
Medicamentos
3 com registro
RILUZOL, ZOLCRIS, LFM-RILUZOL

Tem tratamento?

✓ 3 medicamentos específicos desta doença (registro ANVISA, FDA ou SUS/CEAF)
Ver detalhes, fases e interações →
RILUZOLZOLCRISLFM-RILUZOL
Mais 2 moléculas em estudo para esta doença.

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
All ages
🏥
SUS: Cobertura mínimaScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
105 sintomas
👁️
Olhos
33 sintomas
😀
Face
26 sintomas
💪
Músculos
24 sintomas
🦴
Ossos e articulações
22 sintomas
👂
Ouvidos
11 sintomas

+ 218 sintomas em outras categorias

Características mais comuns

—
Anormalidade do movimento ocular
—
Dificuldades alimentares
—
Arreflexia dos membros inferiores
—
Nistagmo horizontal congênito
—
Sensação de dor prejudicada
—
Atividade anormal da cadeia respiratória mitocondrial
474sintomas
Sem dados (474)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 474 características clínicas mais associadas, ordenadas por frequência.

Anormalidade do movimento ocularAbnormality of eye movement
Dificuldades alimentaresFeeding difficulties
Arreflexia dos membros inferioresAreflexia of lower limbs
Nistagmo horizontal congênitoCongenital horizontal nystagmus
Sensação de dor prejudicadaImpaired pain sensation

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa12desde 2014
Total histórico23PubMed
Últimos 10 anos5publicações
Pico19992 papers
Linha do tempo
20202014Hoje · 2026
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

30 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant.

POU4F1POU domain, class 4, transcription factor 1Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (1)
Regulation of TP53 Activity through Association with Co-factors
MECANISMO DE DOENÇA

Ataxia, intention tremor, and hypotonia syndrome, childhood-onset

An autosomal dominant neurodevelopmental disorder characterized by global developmental delay, mildly impaired intellectual development with speech delay or learning disabilities, delayed walking due to ataxia, intention tremor, and hypotonia apparent from early childhood. Brain imaging shows cerebellar atrophy in some patients.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
2.1 TPM
Linfócitos
0.4 TPM
Brain Spinal cord cervical c-1
0.4 TPM
Skin Sun Exposed Lower leg
0.1 TPM
Skin Not Sun Exposed Suprapubic
0.1 TPM
OUTRAS DOENÇAS (2)
ataxia, intention tremor, and hypotonia syndrome, childhood-onsetcerebellar dysfunction with variable cognitive and behavioral abnormalities
HGNC:9218UniProt:Q01851
ATP1A3Sodium/potassium-transporting ATPase subunit alpha-3Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (3)
Ion homeostasisIon transport by P-type ATPasesPotential therapeutics for SARS
MECANISMO DE DOENÇA

Dystonia 12

An autosomal dominant dystonia-parkinsonism disorder. Dystonia is defined by the presence of sustained involuntary muscle contractions, often leading to abnormal postures. DYT12 patients develop dystonia and parkinsonism between 15 and 45 years of age. The disease is characterized by an unusually rapid evolution of signs and symptoms. The sudden onset of symptoms over hours to a few weeks, often associated with physical or emotional stress, suggests a trigger initiating a nervous system insult resulting in permanent neurologic disability.

OUTRAS DOENÇAS (6)
developmental and epileptic encephalopathy 99cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndromedystonia 12alternating hemiplegia of childhood 2
HGNC:801UniProt:P13637
TGM6Protein-glutamine gamma-glutamyltransferase 6Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Spinocerebellar ataxia 35

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA35 patients commonly show upper limb involvement and torticollis. There is no cognitive impairment.

EXPRESSÃO TECIDUAL(Não detectado)
Cervix Ectocervix
0.0 TPM
Testículo
0.0 TPM
Skin Sun Exposed Lower leg
0.0 TPM
Skin Not Sun Exposed Suprapubic
0.0 TPM
Esôfago - Mucosa
0.0 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
spinocerebellar ataxia type 35inherited acute myeloid leukemia
HGNC:16255UniProt:O95932
DNMT1DNA (cytosine-5)-methyltransferase 1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (7)
STAT3 nuclear events downstream of ALK signalingNuclear events stimulated by ALK signaling in cancerDefective pyroptosisPRC2 methylates histones and DNADNA methylation
MECANISMO DE DOENÇA

Neuropathy, hereditary sensory, 1E

A neurodegenerative disorder characterized by adult onset of progressive peripheral sensory loss associated with progressive hearing impairment and early-onset dementia.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
84.0 TPM
Testículo
56.6 TPM
Cérebro - Hemisfério cerebelar
54.8 TPM
Cerebelo
53.6 TPM
Fibroblastos
46.5 TPM
OUTRAS DOENÇAS (2)
autosomal dominant cerebellar ataxia, deafness and narcolepsyhereditary sensory neuropathy-deafness-dementia syndrome
HGNC:2976UniProt:P26358
ITPR1Inositol 1,4,5-trisphosphate-gated calcium channel ITPR1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (10)
Ion homeostasisRegulation of insulin secretionFCGR3A-mediated IL10 synthesisAntigen activates B Cell Receptor (BCR) leading to generation of second messengersCLEC7A (Dectin-1) induces NFAT activation
MECANISMO DE DOENÇA

Spinocerebellar ataxia 15

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA15 is an autosomal dominant cerebellar ataxia (ADCA). It is very slow progressing form with a wide range of onset, ranging from childhood to adult. Most patients remain ambulatory.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
82.0 TPM
Cerebelo
76.2 TPM
Artéria coronária
59.8 TPM
Aorta
52.7 TPM
Fallopian Tube
47.8 TPM
OUTRAS DOENÇAS (3)
aniridia-cerebellar ataxia-intellectual disability syndromespinocerebellar ataxia type 29spinocerebellar ataxia type 15/16
HGNC:6180UniProt:Q14643
ATXN8OSPutative protein ATXN8OSDisease-causing germline mutation(s) inDesconhecido
OUTRAS DOENÇAS (2)
spinocerebellar ataxia type 8late-onset Parkinson disease
HGNC:10561UniProt:P0DMR3
IFRD1Interferon-related developmental regulator 1Candidate gene tested inTolerante
EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
41.3 TPM
Artéria tibial
39.6 TPM
Nervo tibial
39.1 TPM
Pulmão
34.4 TPM
Pituitária
31.5 TPM
OUTRAS DOENÇAS (1)
spinocerebellar ataxia type 18
HGNC:5456UniProt:O00458
TMEM240Transmembrane protein 240Disease-causing germline mutation(s) inAltamente restrito
MECANISMO DE DOENÇA

Spinocerebellar ataxia 21

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA21 is characterized by onset in the first decades of life of slowly progressive relatively mild cerebellar ataxia associated with slight extrapyramidal features predominant in older patients and cognitive impairment predominant in younger patients.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
59.7 TPM
Cerebelo
57.9 TPM
Brain Frontal Cortex BA9
28.4 TPM
Córtex cerebral
26.7 TPM
Brain Nucleus accumbens basal ganglia
22.9 TPM
OUTRAS DOENÇAS (1)
spinocerebellar ataxia type 21
HGNC:25186UniProt:Q5SV17
TBPTATA-box-binding proteinDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (10)
Regulation of TP53 Activity through PhosphorylationRNA Polymerase II Promoter EscapeRNA Polymerase II HIV Promoter EscapeRNA Polymerase II Pre-transcription EventsHIV Transcription Initiation
MECANISMO DE DOENÇA

Spinocerebellar ataxia 17

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA17 is an autosomal dominant cerebellar ataxia (ADCA) characterized by widespread cerebral and cerebellar atrophy, dementia and extrapyramidal signs. The molecular defect in SCA17 is the expansion of a CAG repeat in the coding region of TBP. Longer expansions result in earlier onset and more severe clinical manifestations of the disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
52.5 TPM
Linfócitos
28.7 TPM
Fallopian Tube
26.9 TPM
Útero
24.9 TPM
Ovário
24.9 TPM
OUTRAS DOENÇAS (2)
spinocerebellar ataxia type 17late-onset Parkinson disease
HGNC:11588UniProt:P20226
PLD35'-3' exonuclease PLD3Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Role of phospholipids in phagocytosis
MECANISMO DE DOENÇA

Spinocerebellar ataxia 46

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA46 is a slowly progressive, autosomal dominant form with onset in adulthood.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
891.5 TPM
Brain Frontal Cortex BA9
337.8 TPM
Aorta
319.6 TPM
Córtex cerebral
287.5 TPM
Hipotálamo
276.6 TPM
OUTRAS DOENÇAS (1)
spinocerebellar ataxia 46
HGNC:17158UniProt:Q8IV08
FGF14Fibroblast growth factor 14Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (1)
Phase 0 - rapid depolarisation
MECANISMO DE DOENÇA

Spinocerebellar ataxia 27A

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA27A is an autosomal dominant, slowly progressive form characterized by gait disturbances, ataxia with tremor, dysarthria, orofacial dyskinesia, gaze-evoked nystagmus, and learning disabilities. There is significant variability, and patients show various combinations of neurologic features.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
20.7 TPM
Cerebelo
16.5 TPM
Brain Frontal Cortex BA9
7.5 TPM
Brain Nucleus accumbens basal ganglia
5.5 TPM
Córtex cerebral
4.9 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (3)
spinocerebellar ataxia 27Aspinocerebellar ataxia 27B, late-onsetspinocerebellar ataxia type 27
HGNC:3671UniProt:Q92915
PLEKHG4Puratrophin-1Candidate gene tested inTolerante
VIAS BIOLÓGICAS (3)
RAC1 GTPase cycleCDC42 GTPase cycleRHOA GTPase cycle
EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
78.0 TPM
Ovário
30.6 TPM
Fibroblastos
23.8 TPM
Nervo tibial
17.9 TPM
Mama
14.2 TPM
OUTRAS DOENÇAS (1)
spinocerebellar ataxia type 4
HGNC:24501UniProt:Q58EX7
ATXN8Ataxin-8Disease-causing germline mutation(s) inDesconhecido
MECANISMO DE DOENÇA

Spinocerebellar ataxia 8

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA8 is an autosomal dominant cerebellar ataxia (ADCA). It is caused by expansion of a CAG repeat in ATXN8, which is translated into a nearly pure polyglutamine protein which forms 1C2-positive inclusions in Purkinje cells and other neurons.

OUTRAS DOENÇAS (1)
spinocerebellar ataxia type 8
HGNC:32925UniProt:Q156A1
PRKCGProtein kinase C gamma typeDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (6)
WNT5A-dependent internalization of FZD4Trafficking of GluR2-containing AMPA receptorsDisinhibition of SNARE formationG alpha (z) signalling eventsResponse to elevated platelet cytosolic Ca2+
MECANISMO DE DOENÇA

Spinocerebellar ataxia 14

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA14 is an autosomal dominant cerebellar ataxia (ADCA).

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Nucleus accumbens basal ganglia
98.9 TPM
Córtex cerebral
73.1 TPM
Brain Frontal Cortex BA9
72.3 TPM
Cerebelo
61.0 TPM
Hipocampo
61.0 TPM
OUTRAS DOENÇAS (1)
spinocerebellar ataxia type 14
HGNC:9402UniProt:P05129
PPP2R2BSerine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoformDisease-causing germline mutation(s) inAltamente restrito
MECANISMO DE DOENÇA

Spinocerebellar ataxia 12

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA12 is an autosomal dominant cerebellar ataxia (ADCA).

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Frontal Cortex BA9
29.9 TPM
Brain Nucleus accumbens basal ganglia
24.8 TPM
Córtex cerebral
24.7 TPM
Brain Caudate basal ganglia
22.5 TPM
Brain Anterior cingulate cortex BA24
20.2 TPM
OUTRAS DOENÇAS (1)
spinocerebellar ataxia type 12
HGNC:9305UniProt:Q00005
PNPT1Polyribonucleotide nucleotidyltransferase 1, mitochondrialDisease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (1)
Mitochondrial RNA degradation
MECANISMO DE DOENÇA

Combined oxidative phosphorylation deficiency 13

A mitochondrial disorder characterized by early onset severe encephalomyopathy, dystonia, choreoathetosis, bucofacial dyskinesias and combined mitochondrial respiratory chain deficiency. Nerve conductions velocities are decreased. Levels of plasma and cerebrospinal fluid lactate are increased.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
39.7 TPM
Fibroblastos
26.0 TPM
Cérebro - Hemisfério cerebelar
21.3 TPM
Brain Spinal cord cervical c-1
20.7 TPM
Testículo
20.4 TPM
OUTRAS DOENÇAS (4)
spinocerebellar ataxia type 25combined oxidative phosphorylation defect type 13autosomal recessive nonsyndromic hearing loss 70hearing loss, autosomal recessive
HGNC:23166UniProt:Q8TCS8
PDYNProenkephalin-BDisease-causing germline mutation(s) inModerado
VIAS BIOLÓGICAS (2)
G alpha (i) signalling eventsPeptide ligand-binding receptors
MECANISMO DE DOENÇA

Spinocerebellar ataxia 23

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA23 is an adult-onset autosomal dominant form characterized by slowly progressive gait and limb ataxia, with variable additional features, including peripheral neuropathy and dysarthria.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Nucleus accumbens basal ganglia
108.5 TPM
Brain Caudate basal ganglia
26.5 TPM
Brain Putamen basal ganglia
11.1 TPM
Testículo
8.9 TPM
Hipotálamo
6.7 TPM
OUTRAS DOENÇAS (1)
spinocerebellar ataxia type 23
HGNC:8820UniProt:P01213
ATXN3Ataxin-3Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
FOXO-mediated transcription of oxidative stress, metabolic and neuronal genesJosephin domain DUBs
MECANISMO DE DOENÇA

Spinocerebellar ataxia 3

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to cerebellum degeneration with variable involvement of the brainstem and spinal cord. SCA3 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. The molecular defect in SCA3 is the a CAG repeat expansion in ATX3 coding region. Longer expansions result in earlier onset and more severe clinical manifestations of the disease.

OUTRAS DOENÇAS (5)
Machado-Joseph diseaseMachado-Joseph disease type 3Machado-Joseph disease type 2Machado-Joseph disease type 1
HGNC:7106UniProt:P54252
CCDC88CProtein DapleDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Negative regulation of TCF-dependent signaling by DVL-interacting proteins
MECANISMO DE DOENÇA

Hydrocephalus, congenital, 1

A form of congenital hydrocephalus, a disease characterized by onset in utero of enlarged ventricles due to accumulation of ventricular cerebrospinal fluid. Affected individuals may have neurologic impairment. HYC1 inheritance is autosomal recessive.

INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (3)
hydrocephalus, nonsyndromic, autosomal recessive 1spinocerebellar ataxia type 40congenital non-communicating hydrocephalus
HGNC:19967UniProt:Q9P219
ELOVL4Very long chain fatty acid elongase 4Disease-causing germline mutation(s) inModerado
VIAS BIOLÓGICAS (1)
Synthesis of very long-chain fatty acyl-CoAs
MECANISMO DE DOENÇA

Stargardt disease 3

A form of Stargardt disease, a common hereditary macular degeneration characterized by decreased central vision, atrophy of the macula and underlying retinal pigment epithelium, and frequent presence of prominent flecks in the posterior pole of the retina. STGD3 is an autosomal dominant form with onset most commonly in the second decade of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Sun Exposed Lower leg
68.2 TPM
Skin Not Sun Exposed Suprapubic
64.1 TPM
Cérebro - Hemisfério cerebelar
43.9 TPM
Cerebelo
27.9 TPM
Brain Frontal Cortex BA9
23.3 TPM
OUTRAS DOENÇAS (4)
spinocerebellar ataxia type 34Stargardt disease 3congenital ichthyosis-intellectual disability-spastic quadriplegia syndromeStargardt disease
HGNC:14415UniProt:Q9GZR5
PUM1Pumilio homolog 1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
Golgi Associated Vesicle Biogenesis
MECANISMO DE DOENÇA

Neurodevelopmental disorder with motor abnormalities, seizures, and facial dysmorphism

An autosomal dominant disorder characterized by global developmental delay, impaired intellectual development, early-onset seizures, poor overall growth, delayed walking, hypotonia and/or ataxia, and facial dysmorphism. Some patients have hypoplasia of the corpus callosum and cerebral atrophy.

EXPRESSÃO TECIDUAL(Ubíquo)
Útero
56.0 TPM
Ovário
54.0 TPM
Nervo tibial
52.9 TPM
Artéria tibial
52.6 TPM
Cérebro - Hemisfério cerebelar
51.0 TPM
OUTRAS DOENÇAS (2)
neurodevelopmental disorder with motor abnormalities, seizures, and facial dysmorphismspinocerebellar ataxia 47
HGNC:14957UniProt:Q14671
ATXN1Ataxin-1Disease-causing germline mutation(s) inAltamente restrito
MECANISMO DE DOENÇA

Spinocerebellar ataxia 1

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to cerebellum degeneration with variable involvement of the brainstem and spinal cord. SCA1 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. SCA1 is caused by expansion of a CAG repeat in the coding region of ATXN1. Longer expansions result in earlier onset and more severe clinical manifestations of the disease.

OUTRAS DOENÇAS (1)
spinocerebellar ataxia type 1
HGNC:10548UniProt:P54253
ATXN2Ataxin-2Disease-causing germline mutation(s) inAltamente restrito
MECANISMO DE DOENÇA

Spinocerebellar ataxia 2

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to cerebellum degeneration with variable involvement of the brainstem and spinal cord. SCA2 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. SCA2 is characterized by hyporeflexia, myoclonus and action tremor and dopamine-responsive parkinsonism. In some patients, SCA2 presents as pure familial parkinsonism without cerebellar signs.

OUTRAS DOENÇAS (3)
spinocerebellar ataxia type 2amyotrophic lateral sclerosislate-onset Parkinson disease
HGNC:10555UniProt:Q99700
ZFHX3Zinc finger homeobox protein 3Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
RUNX3 regulates CDKN1A transcription
MECANISMO DE DOENÇA

Atrial fibrillation, familial, 8

A familial form of atrial fibrillation, a common sustained cardiac rhythm disturbance. Atrial fibrillation is characterized by disorganized atrial electrical activity and ineffective atrial contraction promoting blood stasis in the atria and reduces ventricular filling. It can result in palpitations, syncope, thromboembolic stroke, and congestive heart failure.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
34.3 TPM
Aorta
20.0 TPM
Artéria coronária
19.8 TPM
Tireoide
15.9 TPM
Bladder
13.3 TPM
OUTRAS DOENÇAS (3)
spinocerebellar ataxia type 4prostate cancer, hereditaryatrial fibrillation, familial, 8
HGNC:HGNC:777UniProt:Q15911
CAMTA1Calmodulin-binding transcription activator 1Disease-causing germline mutation(s) inAltamente restrito
MECANISMO DE DOENÇA

Cerebellar dysfunction with variable cognitive and behavioral abnormalities

An autosomal dominant neurodevelopmental disorder characterized by mildly delayed psychomotor development, early onset of cerebellar ataxia, and intellectual disability later in childhood and adult life. Other features may include neonatal hypotonia, dysarthria, and dysmetria. Brain imaging in some patients shows cerebellar atrophy. Dysmorphic facial features are variable.

INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (2)
cerebellar dysfunction with variable cognitive and behavioral abnormalitiesepithelioid hemangioendothelioma
HGNC:18806UniProt:Q9Y6Y1
KCND3A-type voltage-gated potassium channel KCND3Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (2)
Phase 1 - inactivation of fast Na+ channelsVoltage gated Potassium channels
MECANISMO DE DOENÇA

Spinocerebellar ataxia 19

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA19 is a relatively mild, cerebellar ataxic syndrome with cognitive impairment, pyramidal tract involvement, tremor and peripheral neuropathy, and mild atrophy of the cerebellar hemispheres and vermis.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
62.6 TPM
Cerebelo
56.0 TPM
Brain Frontal Cortex BA9
23.7 TPM
Córtex cerebral
19.4 TPM
Esôfago - Muscular
16.0 TPM
OUTRAS DOENÇAS (3)
spinocerebellar ataxia type 19/22Brugada syndrome 9Brugada syndrome
HGNC:6239UniProt:Q9UK17
KCNC3Voltage-gated potassium channel KCNC3Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Voltage gated Potassium channels
MECANISMO DE DOENÇA

Spinocerebellar ataxia 13

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA13 is an autosomal dominant cerebellar ataxia (ADCA) characterized by slow progression and variable age at onset, ranging from childhood to late adulthood. Intellectual disability can be present in some patients.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
78.2 TPM
Tireoide
63.5 TPM
Cérebro - Hemisfério cerebelar
61.8 TPM
Pituitária
24.0 TPM
Brain Frontal Cortex BA9
22.1 TPM
OUTRAS DOENÇAS (1)
spinocerebellar ataxia type 13
HGNC:6235UniProt:Q14003
AFG3L2Mitochondrial inner membrane m-AAA protease component AFG3L2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Processing of SMDT1Mitochondrial protein degradation
MECANISMO DE DOENÇA

Spinocerebellar ataxia 28

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA28 is an autosomal dominant cerebellar ataxia (ADCA) with a slow progressive course and no evidence of sensory involvement or cognitive impairment.

OUTRAS DOENÇAS (3)
optic atrophy 12spinocerebellar ataxia type 28spastic ataxia 5
HGNC:315UniProt:Q9Y4W6
DAB1Disabled homolog 1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
Reelin signalling pathway
MECANISMO DE DOENÇA

Spinocerebellar ataxia 37

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA37 is an autosomal dominant form characterized by adult-onset of slowly progressive gait instability, frequent falls, and dysarthria associated with cerebellar atrophy on brain imaging.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
23.7 TPM
Cerebelo
19.4 TPM
Nervo tibial
7.7 TPM
Hipocampo
5.0 TPM
Brain Anterior cingulate cortex BA24
4.7 TPM
OUTRAS DOENÇAS (1)
spinocerebellar ataxia type 37
HGNC:2661UniProt:O75553
NOP56Nucleolar protein 56Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
rRNA modification in the nucleus and cytosolMajor pathway of rRNA processing in the nucleolus and cytosol
MECANISMO DE DOENÇA

Spinocerebellar ataxia 36

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA36 is characterized by complicated clinical features, with ataxia as the first symptom, followed by characteristic late-onset involvement of the motor neuron system. Ataxic symptoms, such as gait and truncal instability, ataxic dysarthria, and uncoordinated limbs, start in late forties to fifties. Characteristically, affected individuals exhibit tongue atrophy with fasciculation. Progression of motor neuron involvement is typically limited to the tongue and main proximal skeletal muscles in both upper and lower extremities.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
117.5 TPM
Fibroblastos
91.0 TPM
Cerebelo
82.4 TPM
Cérebro - Hemisfério cerebelar
79.2 TPM
Ovário
71.6 TPM
OUTRAS DOENÇAS (1)
spinocerebellar ataxia type 36
HGNC:15911UniProt:O00567

Medicamentos e terapias

RILUZOLEPhase 3

Mecanismo: Sodium channel alpha subunit blocker

LITHIUM CARBONATEPhase 2

Mecanismo: Glycogen synthase kinase-3 inhibitor

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

576 variantes patogênicas registradas no ClinVar.

🧬 POU4F1: NM_006237.4(POU4F1):c.266C>G (p.Pro89Arg) ()
🧬 POU4F1: NM_006237.4(POU4F1):c.1168G>T (p.Glu390Ter) ()
🧬 POU4F1: NM_006237.4(POU4F1):c.421_425del (p.Gly141fs) ()
🧬 POU4F1: NM_006237.4(POU4F1):c.106_113del (p.Cys36fs) ()
🧬 POU4F1: GRCh37/hg19 13q14.3-31.2(chr13:54206989-88417670)x1 ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 454 variantes classificadas pelo ClinVar.

68
341
45
Patogênica (15.0%)
VUS (75.1%)
Benigna (9.9%)
VARIANTES MAIS SIGNIFICATIVAS
DAGLA: NM_006133.3(DAGLA):c.2437_2446del (p.Leu813fs) [Likely pathogenic]
OPA1-AS1: NM_130837.3(OPA1):c.460A>T (p.Lys154Ter) [Pathogenic]
DNMT1: NM_001130823.3(DNMT1):c.4641G>T (p.Glu1547Asp) [Likely pathogenic]
DNMT1: NM_001130823.3(DNMT1):c.1756A>G (p.Ser586Gly) [Uncertain significance]
DNMT1: NM_001130823.3(DNMT1):c.616G>A (p.Asp206Asn) [Uncertain significance]

Vias biológicas (Reactome)

75 vias biológicas associadas aos genes desta condição.

Regulation of TP53 Activity through Association with Co-factors Ion homeostasis Ion transport by P-type ATPases Potential therapeutics for SARS PRC2 methylates histones and DNA NoRC negatively regulates rRNA expression SUMOylation of DNA methylation proteins DNA methylation STAT3 nuclear events downstream of ALK signaling Defective pyroptosis Nuclear events stimulated by ALK signaling in cancer PLC beta mediated events Effects of PIP2 hydrolysis Elevation of cytosolic Ca2+ levels DAG and IP3 signaling Role of phospholipids in phagocytosis FCERI mediated Ca+2 mobilization Glucagon-like Peptide-1 (GLP1) regulates insulin secretion Ca2+ pathway cGMP effects Regulation of insulin secretion VEGFR2 mediated cell proliferation CLEC7A (Dectin-1) induces NFAT activation FCGR3A-mediated IL10 synthesis Antigen activates B Cell Receptor (BCR) leading to generation of second messengers HIV Transcription Initiation RNA Polymerase II HIV Promoter Escape Transcription of the HIV genome SIRT1 negatively regulates rRNA expression B-WICH complex positively regulates rRNA expression RNA Polymerase II Pre-transcription Events Regulation of TP53 Activity through Phosphorylation RNA polymerase II transcribes snRNA genes RNA Polymerase I Transcription Initiation RNA Polymerase I Promoter Escape RNA Polymerase II Promoter Escape RNA Polymerase II Transcription Pre-Initiation And Promoter Opening RNA Polymerase I Transcription Termination RNA Polymerase III Abortive And Retractive Initiation RNA Polymerase II Transcription Initiation RNA Polymerase II Transcription Initiation And Promoter Clearance RNA Polymerase III Transcription Initiation From Type 1 Promoter RNA Polymerase III Transcription Initiation From Type 2 Promoter RNA Polymerase III Transcription Initiation From Type 3 Promoter Estrogen-dependent gene expression Synthesis of PG Phase 0 - rapid depolarisation RHOA GTPase cycle CDC42 GTPase cycle RAC1 GTPase cycle Calmodulin induced events Disinhibition of SNARE formation Trafficking of GluR2-containing AMPA receptors G alpha (z) signalling events WNT5A-dependent internalization of FZD4 Response to elevated platelet cytosolic Ca2+ Mitochondrial RNA degradation Opioid Signalling G-protein activation Peptide ligand-binding receptors G alpha (i) signalling events Josephin domain DUBs FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes Negative regulation of TCF-dependent signaling by DVL-interacting proteins Synthesis of very long-chain fatty acyl-CoAs Golgi Associated Vesicle Biogenesis RUNX3 regulates CDKN1A transcription Voltage gated Potassium channels Phase 1 - inactivation of fast Na+ channels Processing of SMDT1 Mitochondrial protein degradation Reelin signalling pathway Association of TriC/CCT with target proteins during biosynthesis rRNA modification in the nucleus and cytosol Major pathway of rRNA processing in the nucleolus and cytosol

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 31
2Fase 21
Medicamentos catalogadosEnsaios clínicos· 2 medicamentos · 0 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Ataxia cerebelosa autossômica dominante tipo I

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Ataxia cerebelosa autossômica dominante tipo I.

É de uma associação que acompanha esta doença? Fale com a gente →

Doença com base genética

Um médico geneticista pode ajudar no diagnóstico de Ataxia cerebelosa autossômica dominante tipo I e no aconselhamento genético da família.

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Respostas geradas por IA a partir das fontes citadas

É um grupo de ataxias espinocerebelares genéticas que afetam a coordenação e o equilíbrio. O quadro pode se manifestar em qualquer idade e envolve problemas motores e neurológicos.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

5 publicações do grafo RarasNet (PubMed) · 6 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. ORPHA:94145
    Orphanet
  2. GARD:19252
    GARD (NIH)
  3. Q55346087
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (s.d.). Ataxia cerebelosa autossômica dominante tipo I. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/ataxia-cerebelosa-autossomica-dominante-tipo-i

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Ataxia cerebelosa autossômica dominante tipo I

ORPHA:94145 · MONDO:0019792
Prevalência
Unknown
Herança
Autosomal dominant
Medicamentos
2 registrados
Início
All ages
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C5680259
EuropePMC
Wikidata
Papers 10a

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Dado público estruturado
fonte: Wikidata
Moléculas estudadas na doença
fonte: OpenTargets
Rara